Search results
Author(s):
Michael R Zile
Added:
1 year ago
HFA 24 - We are joined onsite by Dr Michael Zile (Medical University of South Carolina, US) to discuss the outcomes of the RELIEVE-HF trial.RELIEVE-HF is designed to evaluate the safety and effectiveness of the V-Wave interatrial shunt system in patients with heart failure. 605 participants with New York Heart Association (NYHA) functional class II, class III or class IV heart failure, who had…
View more
Author(s):
Anne Alexandrov
Added:
1 year ago
AHA ISC 2024 — Dr Anne Alexandrov (University of Tennessee Health Science Center, US) joins us to summarise the key findings from the Zero Degree Head Positioning in Hyperacute Large Artery Ischaemic Stroke (ZODIAC) trial (NCT03728738).ZODIAC is a prospective randomized open blinded endpoint (PROBE) clinical trial investigating head positioning in hyperacute LVO ischemic stroke treatment. It aims…
View more
Author(s):
Maki Komiyama
,
Moritake Iguchi
,
Hiromichi Wada
,
et al
Added:
10 months ago
Daniel Tak Mao Chan
Research Area(s) / Expertise:
Job title: Chief of Nephrology Division, The University of Hong Kong (HKU), Hong Kong, China
Author
Barinda Agian Jeffilano
Research Area(s) / Expertise:
Author
Expertise
Author(s):
Tian-le Li
,
Mao-long Fu
,
Li-hong Wang
,
et al
Added:
1 month ago
Added:
1 year ago
Source:
Radcliffe Cardiology
AUTHOR: Brad WilsonIn a study published in the Journal of the American College of Cardiology (JACC), Dr Elias Björnson and his colleagues demonstrated that lipoprotein(a) (Lp(a)) is approximately six times more atherogenic than low-density lipoprotein (LDL) per particle.Lp(a) is a lipoprotein particle that has long been recognised as a causal factor for coronary heart disease (CHD). However,…
View more
Chan Hong
Research Area(s) / Expertise:
Author
Expertise
David Birnie
Job title: Cardiac Electrophysiologist and Deputy Division Head of Cardiology
Author
Author(s):
Shunsuke Kiuchi
,
Shinji Hisatake
,
Yoshiki Murakami
,
et al
Added:
9 months ago